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Neurodevelopmental milestones and associated
behaviours are similar among healthy children
across diverse geographical locations
José Villar1,2, Michelle Fernandes1,3, Manorama Purwar4, Eleonora Staines-Urias1, Paola Di Nicola5,
Leila Cheikh Ismail6, Roseline Ochieng7, Fernando Barros8, Elaine Albernaz9, Cesar Victora10, Naina Kunnawar4,
Sophie Temple1, Francesca Giuliani5, Tamsin Sandells1, Maria Carvalho7, Eric Ohuma1,11, Yasmin Jaffer12,
Alison Noble13, Michael Gravett14, Ruyan Pang15, Ann Lambert1, Enrico Bertino16, Aris Papageorghiou1,2,
Cutberto Garza17, Alan Stein18, Zulfiqar Bhutta19 & Stephen Kennedy1,2
It is unclear whether early child development is, like skeletal growth, similar across diverse
regions with adequate health and nutrition. We prospectively assessed 1307 healthy, well-
nourished 2-year-old children of educated mothers, enrolled in early pregnancy from urban
areas without major socioeconomic or environmental constraints, in Brazil, India, Italy, Kenya
and UK. We used a specially developed psychometric tool, WHO motor milestones and
visual tests. Similarities across sites were measured using variance components analysis and
standardised site differences (SSD). In 14 of the 16 domains, the percentage of total variance
explained by between-site differences ranged from 1.3% (cognitive score) to 9.2% (beha-
viour score). Of the 80 SSD comparisons, only six were >±0.50 units of the pooled SD for the
corresponding item. The sequence and timing of attainment of neurodevelopmental mile-
stones and associated behaviours in early childhood are, therefore, likely innate and universal,
as long as nutritional and health needs are met.
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The INTERGROWTH-21
st Project consisted of several
interrelated studies with the primary aim of assessing
growth, health, nutrition and neurodevelopment from less
than 14 weeks’ gestation to 2 years of age, using the same con-
ceptual framework as the WHO Multicentre Growth Reference
Study1. Eight study populations across diverse geographically
delimited areas were selected according to criteria for adequate
health, nutrition and socioeconomic status required for con-
structing international standards2,3. The Project has produced
prescriptive, international standards of fetal growth4, newborn
size and body composition5,6, and postnatal growth of preterm
infants7. The standards complement the existing WHO Child
Growth Standards8 very well and clearly demonstrate that par-
ticipants in the INTERGROWTH-21st Project were appropriately
selected to meet the WHO prescriptive criteria for optimal
human growth and neurodevelopment9.
The studies provided robust evidence of the similarities in
skeletal growth from early pregnancy to 2 years of age, based on
WHO recommended strategies10. However, the biological con-
cept of similarities across non-isolated populations should be
extended beyond skeletal growth9, to include markers of neuro-
development. This is justified because cognition, attentional
problems, language, motor and visual capacity are fundamental
human functions, and their development reflects the fast growth
and maturation of the brain11, which accompany the rapid ske-
letal growth that occurs in fetuses and infants12.
The first step in our research programme was to develop, vali-
date and test in different settings a simplified, rapid, neurodeve-
lopment assessment package that would measure key dimensions
of neurodevelopment and associated behaviours separately and
objectively, and that could be used internationally across different
cultures and administered to large populations13–15.
Here, we report the findings of the second step in the pro-
gramme. Using the INTERGROWTH-21st Neurodevelopment
Assessment Package which we developed, we demonstrate, for the
first time in a longitudinal study from pregnancy to childhood,
that the sequence and timing of attainment of key neurodeve-
lopmental milestones and associated behaviours among 2-year-
old children are similar across geographically delimited popula-
tions specially selected because of their adequate health, medical
care, education, and nutrition. We also show that the data from
the five study sites can be pooled to create international standards
because the variation in child development “between” sites is
minimal compared to other sources of variance.
Results
Study participants. There were 2898 singleton fetuses, born alive
without congenital malformations, that were included in the
construction of the international INTERGROWTH-21st Fetal
Growth4 and Preterm Postnatal Growth Standards7, from five
study sites located in the cities of Pelotas (Brazil); Turin (Italy);
Oxford (UK); the central area of Nagpur (India) and the Park-
lands suburb of Nairobi (Kenya). All were urban regions (e.g. a
complete city, or county, or part of a city with clear political or
geographical limits where most deliveries occurred in health
institutions). The selection criteria at the cluster level were: the
areas had to be located at an altitude <1600 m, with a low risk of
fetal and infant growth and developmental disturbances as well as
an absence or low levels of major, known, non-microbiological
contamination such as pollution, domestic smoke, radiation or
any other toxic substances. Within each urban area, we selected
all institutions classified locally as “private” or “corporation”
hospitals and/or serving the middle to upper socioeconomic
population provided that most of the institutional deliveries from
the target population took place there. Women receiving
antenatal care had to plan to deliver in these institutions or in a
similar hospital located in the same geographical area. Three
original sites located in China, Oman and the USA did not
participate in the sub-studies that are the focus of the present
report.
One hundred and ninety women were lost to follow-up or
withdrew consent soon after pregnancy or their neonates died
before hospital discharge. Although this was an a priori designed
follow-up study, there was delay in obtaining the required
funding. Hence, by the time the follow-up started, 833 children
were considered unlikely to be evaluated within the assessment
age-window, as per protocol. Additionally, 117 parents withdrew
consent.
From the 1758 remaining children, five died during infancy
and 83 had a clinical evaluation but not the complete
neurodevelopment assessment (Fig. 1). We also could not contact
331 parents. Thus, of the 1753 eligible children, 1422 (81.1%)
were seen at 2 years and 1339 (76.4% of all those eligible) had a
neurodevelopment assessment. Among the latter, 32 children
were diagnosed with severe visual problems, seizures, hearing
impairment, malaria or heart conditions. The diagnoses were
made as part of routine clinical care by the appropriate clinicians;
consistency across sites was maintained by providing a manual of
operations to standardise care, which is freely available at www.
intergrowth21.org.uk. These children were excluded from the
final analysis, leaving data from 1307 available children (683 girls
and 624 boys) (Fig. 1).
The proportional contribution to the analysis sample from the
study sites was 15% Brazil (N= 199), 24% India (N= 318), 24%
Italy (N= 311), 24% Kenya (N= 311) and 13% the UK (N=
168). The baseline socio-demographic characteristics (Supple-
mentary Table 1) of these samples were remarkably similar to
those of the original cohorts at each study site2, and the samples
across the five sites were, as expected, also similar because the
same entry criteria were used. In addition, the satisfactory growth
and development of the children at 1 and 2 years of age has
confirmed the adequate health, educational and nutritional status
of the original cohorts9.
The median, inter-quartile range (IQR) age at the neurodeve-
lopment assessment was 24.2 (IQR 23.9, 25.2) months; 1128
(86.4%) children were evaluated between 22 and 26 months. The
neonatal characteristics of the children evaluated at 2 years
(n= 1307) were compared to those of the children lost to follow-
up (n= 331). The two samples were very similar in terms of
anthropometric measures at birth, preterm birth rate, sex and
neonatal morbidity. At hospital discharge, over 90% of newborns
were exclusively breastfed in both groups (Table 1).
Exclusive/predominant breastfeeding was discontinued at a
median of 5.5 (IQR 4.0, 6.0) months in the evaluated group and at
5.0 (IQR 3.0, 6.0) months in the non-evaluated group.
Breastfeeding stopped entirely at a median of 12.0 (IQR 7.0,
18.0) months in the evaluated group. The median years of
maternal education in the evaluated group were 15.0 (IQR 13.0,
17.0) and 15.0 (IQR 12.0,16.0) in the non-evaluated group.
The majority of infants were vaccinated in accordance with
recommended policies and only 16.5% were treated with iron/
vitamins. The most frequently reported or diagnosed conditions
during the second year of life were exanthema/skin diseases,
fever ≥ 3 days during ≥3 episodes, and otitis media/lower-tract
respiratory infections. Antibiotics were prescribed to 12.5% of
children during their second year. Overall, the children evaluated
had low morbidity in accordance with their mothers’ low-risk
status, the very low preterm birth rate (4%) and the families’
socioeconomic and educational status (Tables 1 and 2).
By 2 years, 92% of length, 90% of weight and 91% of head
circumference measures of this cohort’s values were within the
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3rd and 97th centiles of the WHO Child Growth Standards.
Among infants born at term, the mean (SD) age- and sex-specific
z-scores for length, weight and head circumference were −0.15
(1.00), 0.23 (1.05) and 0.13 (1.08), respectively.
Developmental measures. The number of observations available
across sites for individual domains of the INTERGROWTH-21st
Neurodevelopment Assessment, Cardiff tests and age of
achievement of two WHO gross motor development milestones
are shown in Supplementary Table 2. Ninety-nine percent of
children reached the milestone of the age at “first standing alone”
and 98% reached the milestone of the age at “walking alone”
within the 3rd and 97th centiles of the WHO age-window of
achievement16. Furthermore, 99% of children had binocular
visual acuity of 0.4 log Mar (6/15 Snellen equivalent) or better,
and 98.4% had visual contrast sensitivity of 33.3 or higher sug-
gesting that they did not have any visual impairment17.
The mean ages at assessment were almost identical for girls and
boys (25.1; SD 2.2 and 25.0; SD 2.1 months, respectively). There
FGLS infants reaching 2 years of
age after NDA started in five
participating sites
n = 1758
Infants eligible for
neurodevelopment assessment
n = 1753
Infants with neurodevelopment
assessment data
n = 1339
Severe morbidity /
neurological conditions
Healthy infants with
neurodevelopment assessment
data
n = 1307
Infant death
Lost to follow-up
(76%)
2-year contact without NDA
Visit outside centre
Uncooperative child
Other reason
n = 5
n = 331
n = 32
n = 30
n = 9
n = 44
n = 83
Fig. 1 Participant flow: INTERGROWTH-21st Project Neurodevelopment Assessment cohort at 2 years of age
Table 1 Neonatal characteristics of children included in the INTERGROWTH-21st Neurodevelopment Assessment Study
compared to children lost to follow-up
Children evaluated (n= 1307) Children lost to follow-up (n= 331)
Gestational age at delivery, weeks 39.4 (1.5) 39.3 (1.5)
Birthweight, kg 3.2 (0.5) 3.2 (0.5)
Birth length, cm 49.0 (2.0) 49.0 (2.1)
Head circumference at birth, cm 33.9 (1.4) 34.0 (1.3)
Apgar at 5 min 9.5 (0.6) 9.6 (0.7)
Age at hospital discharge, daysa 3.0 (2.0, 4.0) 2.0 (1.0, 3.0)
Boys 624 (47.7) 160 (48.3)
Preterm birth (<37 weeks’ gestation by LMP) 54 (4.1) 16 (4.8)
Early preterm (<34 weeks’ gestation by LMP) 6 (0.5) 2 (0.6)
NICU stay > 1 day; <3 days 47 (3.6) 18 (5.5)
NICU > 3 days 33 (2.5) 12 (3.6)
Hyperbilirubinaemia 66 (5.1) 18 (5.5)
Respiratory distress syndrome 29 (2.2) 7 (2.1)
Transient tachypnoea of the newborn 18 (1.4) 12 (3.6)
Exclusive breastfeeding at hospital discharge 1209 (92.6) 300 (90.9)
Data are means (SD) or proportions (%) unless otherwise specified. Missing data below 2% for all variables
LMP last menstrual period, NICU neonatal intensive care unit
aMedian (inter-quartile range)
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was a trend towards higher average values in the cognitive and
motor scores among girls, which was inverted for attention and
language scores in favour of boys but without a clear overall
differential pattern. Nevertheless, we have adjusted all compar-
isons across study sites by sex. As expected, the age of the
children (in months) at the time of assessment had an effect, i.e.
older children, even within the assessment age-window, had
slightly higher scores. We have, therefore, adjusted all compar-
isons across study sites for chronological age at assessment.
Table 3 presents the percentage of the total variance that can be
attributed to differences between study sites (as opposed to
differences among individuals within sites) estimated using
variance components analysis in these five healthy, adequately
nourished cohorts.
Amongst the primary domains (top seven domains in Table 3),
the proportion of the total variance adjusted by sex and age at
assessment explained by site differences was 1.3% for the mean
cognitive score and 5.4% for the mean attentional problems score;
for the visual tests and motor domains, site differences explained
8% or less of the total variance for each item. Results from the
models that included sex and age were consistently similar to
those that included fetal and child growth variables.
Furthermore, we selected an item from the cognitive domain
that could be considered as describing one of the three
components of executive function18, i.e. “inhibition on task
performance” (“Identifies glitter bracelet under washcloth”).
Differences between sites explained only 3.4% of the total
variance for this item (Table 3). This is relevant because executive
function describes a set of skills involved in planning complex
behaviours towards the purpose of solving novel problems19.
Similar estimations were made for the seven secondary
domains (Table 3). For positive affect (mood), receptive and
expressive language and overall behaviour, differences between
sites explained between 1.9 and 9.2% of the total variance. The
emotional reactivity (14.2%) and negative behaviour (14.1%)
domains were the only two in which site differences explained a
relatively higher proportion of the total variance (Table 3).
Finally, the same analyses were performed using reported “age
at first standing” and “walking alone”, both fundamental motor
development milestones. The percentage of the total variance
explained by between-site differences was 5.6 and 6.9%,
respectively (last two items of Table 3).
As the second strategy to evaluate similarities between study
sites, the SSD for each of the 16 developmental domains was
estimated for the five sites. The means and SDs were adjusted by
sex and age at assessment, expressed as units of the SD of all sites
combined (Fig. 2). For the seven primary domains complemented
by the two WHO gross motor milestones, there were only two
Table 2 Morbidity diagnoses between 1 and 2 years of life of
children included in the INTERGROWTH-21st
Neurodevelopment Assessment Study
Children in the analysis
(n= 1307)a
Hospitalised at least once 117 (9.0)
Any prescription made by a health-care
practitioner:
771 (59.0)
• Antibiotics (≥3 regimens) 163 (12.5)
•Iron/folic acid/vitamin B12/other
vitamins (≥3 regimens)
216 (16.5)
Up-to-date with local vaccination policies 1231 (94.3)
Otitis media/Pneumonia/Bronchiolitis 98 (7.5)
Parasitosis/Diarrhoea/Vomiting 51 (3.9)
Exanthema/skin disease 159 (12.2)
Urinary tract infection/pyelonephritis 6 (0.5)
Fever≥ 3 days (≥3 episodes) 147 (11.3)
Other infections requiring antibiotics 44 (3.4)
Asthma 15 (1.1)
Gastro-oesophageal reflux 4 (0.3)
Cow’s milk protein allergy 11 (0.8)
Food allergies 15 (1.1)
Injury trauma 34 (2.6)
Surgery 9 (0.7)
Data are number (%). Missing data below 1% for all variables
aFor five children, information on morbidities in the first year of life was used
Table 3 Variance components analysis for individual domains of the INTERGROWTH-21st Neurodevelopment Assessment
Package showing variance between study sites as % of the total variance
Neurodevelopment domain Model with age and sex
(n= 1307)
Model with age, sex and fetal HC
(n= 1302)
Model with age, sex, HC and length at
2 years (n= 1283)
Cognitive score (%)a 1.3 1.2 1.2
Executive function-like (%)a 3.4 3.3 3.3
Attentional problems score (%)b 5.4 5.8 4.1
Visual acuity (%)a 8.0 6.9 7.4
Visual contrast sensitivity (%)a 7.3 7.3 6.9
Fine motor score (%)a 6.0 6.0 6.2
Gross motor score (%)b,c 6.5 7.2 6.7
Receptive language score (%)b,c 1.9 1.4 1.9
Expressive language score (%)b,c 7.3 7.0 7.3
Positive behaviour score (%)c 8.5 8.2 8.7
Negative behaviour score (%)c 14.1 13.6 13.7
Total behaviour score (%)c 9.2 9.2 9.9
Emotional reactivity score (%)b 14.2 15.3 14.0
Positive affect score (%)b 2.5 2.7 2.7
Age when first stood alone (%)b 5.6 5.3 6.5
Age when first walked alone (%)b 6.9 6.9 7.6
Variance components estimated by nonparametric generalised linear mixed models including covariates as fixed effects and study site as random effect
Age age at assessment, fetal HC ultrasound head circumference z-score from 26 to 34 weeks’ gestation compared to the INTERGROWTH-21st Fetal Growth Standards2; Head circumference and length z-
scores at 2 years compared to the WHO Child Growth Standards8
aDirect administration
bCaregiver report
cConcurrent observation
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values of the 45 comparisons outside the pre-specified SSD cut-off
point of ±0.5 (Brazilian site for fine motor: SSD 0.63 and Indian
site for visual acuity: SSD −0.56).
Considering the seven secondary NDA domains (35 compar-
isons), there were only three SSD values outside the pre-specified
range (Brazilian site for expressive language: SSD 0.68, Kenyan
site for negative behaviour: SSD −0.66, and Italian site for
emotional reactivity: SSD −0.70) (Fig. 2).
Discussion
We have presented evidence that healthy, adequately nourished,
well-educated pregnant women, recruited from five diverse geo-
graphical and cultural study sites, who receive recommended
antenatal care, have children that display consistent similarities at
2 years of age across a comprehensive set of neurodevelopmental
outcomes. The evidence complements previous reports from the
INTERGROWTH-21st Project demonstrating equivalent simila-
rities across these study sites for skeletal growth from the first
trimester of pregnancy to 2 years of age9.
In 14 of the 16 domains evaluated, the percentage of variance
explained by between-site differences ranged from 1.3% (cogni-
tive score) to 9.2% (behaviour score) of the total variance. Of the
80 comparisons using SSDs, only six were >±0.50 units of the
pooled SD for the corresponding item, two of them just mar-
ginally outside that limit and without any specific pattern. The
percentage of variance explained by site differences in the emo-
tional reactivity and negative behaviour domains (14%) could be
because the scoring of these items is more culturally dependent,
i.e. negative behaviour could be perceived and hence scored dif-
ferently across settings20.
It is evident that across developmental and growth parameters,
only a very small percentage (around 10%) of the total variance in
these fundamental human functions can be explained by differ-
ences among these populations (Fig. 3). The present results and
previous publications, presented together in Fig. 3, support the
position that most of the observed differences in growth and
neurodevelopment across general populations or countries are
primarily due to socioeconomic, educational and class disparities,
i.e. postal codes define the health profiles of humans better than
their genetic code21.
Our study has some unique features. It is based on a set of
multi-site, prospective cohorts that consisted of healthy, ade-
quately nourished, well-educated mothers and their babies,
enrolled to test a specific hypothesis, that were followed from early
pregnancy to 2 years of age. Anthropometric, visual and gross
motor development scores agreed well within recommended limits
for normal populations. Detailed information was obtained about
the socioeconomic, education and environmental backgrounds of
the families selected at both population and individual levels3. All
clinical, anthropometric measures, feeding practices and mon-
itoring procedures were rigorously standardised across time and
sites. The samples described are not representative of whole
countries, regions or cities, nor were they intended to be. Instead,
they were specifically selected—reflecting our conceptual approach
to the issue—to include geographical areas populated by low-risk
pregnant women and their children within each country or city.
Hence, the samples are intended to represent a theoretical, heal-
thy, low-risk population—rather than one that includes both low-
and high-risk populations—within a country or city.
We initially considered other short assessment tools during the
preparation of the study14. While some employ a global approach,
our study design required a tool based on a multi-country sam-
ple9 that could separately evaluate a range of domains. Moreover,
we were interested in combining psychometric methodologies, i.e.
the direct administration of tasks, concurrent observation of child
performance and caregiver reports, to balance the risk of recall
and reporter bias13. Our efforts at scrutinising the pre-existing
literature showed that such a tool was not available14. Hence, we
developed, standardised and validated a new, domain-focused,
culturally neutral, and simple-to-implement assessment tool13,14.
For maternally reported items on attentional problems and
emotional reactivity, local language versions from validated Child
Behaviour Checklist translations were produced22.
We a priori selected a set of seven primary domains and within
them, the cognitive domain of the INTER-NDA was considered
the primary outcome because its constituent items are directly
administered to the child in task-based sequences; it is less
affected by cultural factors, and it is scored objectively so it is
not affected by recall or parental report bias. The cognitive
domain is also strongly associated with adverse pregnancy out-
comes such as impaired fetal growth23.
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Fig. 2 Standardised site difference for mean scores of individual domains of the INTERGROWTH-21st Project Neurodevelopment Assessment, Cardiff tests
and age of achievement of two WHO gross motor development milestones. The standardised site differences calculated as the site mean of each domain
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Interestingly, the two language domains were considered a
priori secondary outcomes for comparing the cohorts because
of their strong association (particularly expressive language) with
children’s interactions with their cultural environment and the
influence of care providers. However, our observation of
similarities in the children’s performance on the language
domains suggests that, overall, children may not have differed
dramatically in the levels of early stimulation they received from
these urban, well-educated families (median of 15 years of
maternal formal education) (http://data.uis.unesco.org/Index.
aspx?queryid=242).
Alternatively, the findings could support the concept that
language acquisition is mostly a function of cognitive
maturation24,25, affective and social connectedness to other per-
sons (universal to all cultural contexts) and, as such, children with
high levels of cognitive and social functioning would, in most
cases, display similarly high levels of language skills26,27.
We selected 2 years of age as the time-point for the key
development assessment of the entire study because growth
markers at this age have been found to be predictive of intelli-
gence, school performance, adult nutrition and human capital in
high-, middle- and low-income settings28–32. Moreover, this is the
earliest age at which the assessment of development is not con-
founded by transient neurological syndromes of prematurity, and
at which conventionally used developmental instruments, such as
the Bayley Scales of Infant Development, have been found to
possess an acceptable level of medium- and long-term predictive
validity13,33; this age also corresponds to the end of Piaget’s
sensorimotor stage34.
The psychometric properties of the measure we developed, the
INTER-NDA, including internal consistency and construct
validity, evaluation of its performance using interclass correla-
tions for absolute agreement; Bland−Altman analyses for bias
and limits of agreement, and sensitivity and specificity analyses
for accuracy, have all been validated against the Bayley Scales of
Infant Development14,15.
In our statistical analyses, we adjusted by the age of the child at
the developmental assessment, which controls for self-selection of
families attending follow-up clinics, i.e. health-care-seeking pat-
terns. We did not adjust for any characteristics at recruitment
early in pregnancy as the main hypothesis of the paper is to
evaluate the differences among the study samples that were
selected using the same entry criteria. We opted for this con-
servative approach because further adjustment for any “residual
confounding” would have made the samples more “artificially”
similar.
We successfully evaluated 76% of the eligible children, despite
the known difficulties in retaining healthy participants in large-
scale, multi-national, follow-up studies. Selection bias is unlikely
in view of the baseline similarities between the children evaluated
and those lost to follow-up. Unfortunately, we could not include
three of the original sites that participated in the
INTERGROWTH-21st Project because initiation of the follow-up
study was delayed due to the funding process. This reduced the
external validity of our observations although we retained five
study sites on four continents, with distinct geographical and
cultural identities. It also affected the total size of the original
cohort; however, this is less relevant to our hypothesis because the
comparisons were focused on the sites that contributed data,
which retained a large proportion of their original sample.
An additional limitation of the analysis is that we did not have
repeated developmental measures: hence, while we were able to
estimate the percentage of variance explained by “between sites’
variation”, i.e. the main hypothesis of this study, it would have
been informative to estimate the “within site variation” but this
requires individual repeated measures at different ages. There are
considerable conceptual difficulties in identifying comparable
repeated measures of developmental domains at both 1 and 2
years of age. We have, however, recently published results com-
paring the percentage of “within” versus “between” sites variance
for repeated skeletal growth measures, i.e. infant length for the
same cohort2. These data for the “between” variance component
0
DEVELOPMENT
Cognitive
Executive function–like
Attentional problems
Visual acuity
Visual contrast sensitivity
Fine motor
Gross motor
Receptive language
Expressive language
Positive behaviour
Negative behaviour
Total behaviour
Emotional reactivity
Positive affect
Standing alone
Walking alone
GROWTH
Length at birth
Child height
Infant and child length
Length – birth to 2 years
Preterm length – birth to six months
1st–trimester fetal CRL
2nd–and 3rd–trimester fetal HC
10 20 30 40 80 90 100
Variance components as
% of total variance across study sites
Fig. 3 Variance components analysis of 16 neurodevelopmental domains evaluated in the present study (upper part) and variance components analysis of 7
measures of fetal, newborn, infant and child growth (lower part). Red bars are the % of total variance explained by between sites variability for each
domain or growth measure. Data for the seven growth measures: INTERGROWTH-21st Project (eight study sites)2,3,5,9; WHO Multicentre Growth
Reference Study (five study sites)8; Habicht et al.41
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(5.5% of the total variance for length), that is considerably lower
than the “within” variance (42.9% of the total variance for
length), are very similar to the results presented here.
An inevitable constraint, inherent in the brief psychometric
tools required to evaluate large populations, is that some domains
are based on only a few items. This was the case in our study for
negative behaviour, positive affect and receptive language, which
were evaluated by two items. Therefore, we concentrated our
interpretation and conclusions on the consistent similarities
observed overall.
Traditionally, developmental comparisons during childhood
across populations have been made between developing and
developed countries; low and high socioeconomic populations;
children of parents with high and medium to low levels of edu-
cation, or immigrant populations with native children in the USA
or Europe35–38. When attempts were made across contexts to
compare levels of parental stimulation, which is key to early child
development (ECD), samples have come from very different
socioeconomic contexts and likely health conditions39,40. These
studies suggested that cognition, language, play and sociability are
heavily influenced by the socioeconomic structures of the society
in which the children are growing up. Such evidence has been
used to explain developmental differences between socio-
economic levels in industrialised societies, where most of the
research has been conducted.
We have approached this fundamental question differently,
although in a complementary manner. We studied cohorts of
healthy, well-educated, adequately nourished women receiving
evidence-based pregnancy care from culturally different geo-
graphical areas that were selected because of their low morbidity
and environmental risks. We have documented that under similar
socioeconomic, health and nutrition conditions, there are
remarkable similarities in the physical growth of their children up
to 2 years of age9, to which we now add evidence of comparable
similarities in the attainment of neurodevelopmental functions
and associated behaviours.
The initial INTERGROWTH-21st Project publications stressed
that the relevant question when comparing healthy, low-risk
populations to identify physical growth differences or similarities
is: whether or not the variability in skeletal growth within a
population, i.e. inter-individual difference, is larger than the
variability between populations, i.e. inter-population difference,
when nutritional, socioeconomic, environmental and health-care
needs are met. There is now consistent evidence that the varia-
bility in human skeletal growth within a population is seven times
larger than that between populations (genetic variability), which
represents less than 10% of the total variance2,8,41,42.
The magnitude of the results presented is entirely consistent
with studies of the genetics of human growth. For example,
genome-wide association studies (GWAS) testing for common
fetal variant effects on birthweight have to date identified as many
as 60 associated genetic loci43, and estimation of the variance in
birthweight due to a distinct maternal genetic contribution ranges
from 3 to 22%43,44. Similarly, GWAS have identified nearly 700
independent variants within over 400 genetic loci that together
explain only 20% of the heritability of adult height45.
Interestingly, a very recent report studied a cross-sectional
sample of clinically healthy, 0-to-42-month-old children using a
short, pre-coded interview with caregivers to assess age of
achievement of 106 developmental milestones. The study was
conducted in 22 health-care clinics in four diverse low-middle
income countries (LMICs) with ethnic, cultural, and language
differences46. Using predefined criteria of practical equivalence,
almost all milestones at 1 year of age and 76% of the milestones
up to 3 years of age were attained at similar ages across the four
study sites. Despite the considerable methodological differences
with our study, this report provides evidence from four other
populations of the similarities of early developmental patterns
among healthy children. The authors concluded with the state-
ment that internationally applicable tools were needed to “assess
children’s development to guide policy, service delivery, and
intervention research that might help narrow the gap between
high-income countries and LMICs in addressing early childhood
development”.
We agree completely with this statement, especially in the light
of the similarities in results obtained for anthropometric mea-
sures across populations when health and nutritional needs are
met. International prescriptive standards for ECD are recom-
mended for both clinical practice and research as many of the
tools currently used are based on very skewed populations from
developed countries, which little resemble present, culturally
mixed societies. For example, personality tests, which have been
used on millions of subjects worldwide, were constructed using a
few hundred Swiss-German patients in the 1960s in the case of
the Rorschach test, and white, rural, Protestant “Minnesotan
normal” hospital visitors in the 1930s in the case of the Minnesota
Multiphasic Personality Inventory47,48.
Clearly, in clinical settings, it is important to focus on an
individual child as the unit of diagnosis and interventions. At
population level, the first step is to identify children at risk, i.e.
those that require further assessment and are most likely to
benefit from an intervention. However, the heterogeneity of ECD
measures presently in use and their reliance on specialists has
made it difficult to carry out population-based ECD screening.
Our results strongly support the construction of international,
psychometric, ECD standards (manuscript submitted). Our
strategy not only provides more variability to the distribution of
scores, which is desirable for a first-level screening tool, but also
better reflects the underlying constitution of modern multi-
cultural societies.
Finally, it is worth noting that we have deliberately avoided
reporting the race/ethnicity of the participants despite some
widely held beliefs that it influences ECD. We have consistently
argued that the use of self-reported race/ethnicity in scientific
publications is problematic in most non-isolated populations
because, in addition to the inherent biases of self-reporting, there
is large ancestral admixture due to global migration, invasions
and other population movements. Furthermore, there are at least
116 definitions of self-reported race/ethnicity in the biomedical
literature49.
In short, our neurodevelopmental and skeletal growth results
from conception to childhood, as well as the genetic evidence
summarised by Craig Venter in reference to possible links
between race and intelligence: “There is no basis in scientific fact
or in the human genetic code for the notion that skin colour will
be predictive of intelligence” (https://www.theguardian.com/
news/2018/mar/02/the-unwelcome-revival-of-race-science)
strongly support our conclusions.
Methods
Study subjects. INTERGROWTH-21st was a large, multi-centre, population-
based project conducted between 2009 and 2016, in eight delimited geographical
areas worldwide. The primary aim was to study growth, health, nutrition and
neurodevelopment from early pregnancy to 2 years of age in populations of
mothers and children with optimal health. A geographical area was a complete city
or county, or part of a city with clear political or geographical limits, located at an
altitude <1600 m, with low-risk health indicators for perinatal morbidity and
mortality, in which women receiving antenatal care had plans to give birth within
the area, that had to be free or have low levels of major, known, non-
microbiological contamination3.
The Fetal Growth Longitudinal Study (FGLS), one of the main studies of the
INTERGROWTH-21st Project, recruited pregnant women from the
aforementioned populations, who met the individual entry criteria of health,
nutrition, education, and socioeconomic position, and accurate gestational age
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estimation. The objective was to construct international standards for gestational
weight gain, early and late fetal growth, newborn size and preterm postnatal
growth4,5,7,50,51. The cohort enrolled in FGLS was followed up to 2 years of age,
and evaluated for their skeletal growth, nutrition, health and the WHO gross motor
milestones9,16.
Across all study sites, standardised clinical care and feeding practices were
implemented based on protocols developed by the INTERGROWTH-21st Neonatal
Group (http://www.intergrowth21.org.uk). Exclusive breastfeeding up to 6 months
was promoted for all babies, supplementing preterm infants as recommended52.
Standardised information was obtained during pregnancy, at birth and at 1 and 2
years of age on health, anthropometric measures, severe morbidities, length of
breastfeeding, timing of the introduction of food, feeding practices and food intake
using forms specially produced for the project (www.intergrowth21.org). The
baseline characteristics of the full cohort and follow-up methodology have been
published recently9.
For the neurodevelopmental evaluation, children were scheduled for assessment
at 2 years of age in five of the eight original sites: the cities of Pelotas (Brazil), Turin
(Italy), Oxford (UK), the central area of Nagpur (India) and the Parklands suburb
of Nairobi (Kenya) using tools specifically developed or selected for this purpose13.
All participants were part of the original FGLS cohort and contributed data
towards the construction of the international Fetal Growth and the Preterm
Postnatal Growth Standards4,7. The sites in China, Oman and the USA did not
participate because of logistical and administrative reasons, delays in the start of the
study and/or staff availability.
Assessment tools. The INTERGROWTH-21st Neurodevelopment Assessment
(INTER-NDA) is a brief, objective tool, measuring multiple dimensions of early
development, targeted at children aged 22–30 months13. It was designed to be
implemented by non-specialists across international settings14, and includes a
reduced number of culture-specific items measuring cognition, expressive and
receptive language, motor skills (fine and gross), positive and negative behaviour,
attentional problems and social-emotional reactivity (taken from the Child Beha-
vior Checklist)53 using a combination of directly administered, concurrently
observed and caregiver reported items. The INTER-NDA has been validated
against the Bayley Scales of Infant Development III edition47, showing good to
moderate agreement14, and has shown good levels of inter-rater (k= 0.70; 95% CI
0.47–0.88) and test/re-test reliability (k= 0.79; 95% CI 0.48–0.96)13.
The gross motor domain of the INTER-NDA was complemented by the
evaluation of the age of achievement of the matching WHO gross motor
development milestones “standing alone” and “walking alone”16. Information was
obtained at both the 1- and 2-year follow-up visits in order to evaluate consistency.
In cases of disagreement (19 cases out of 1292 for “standing alone” and 18 cases out
of 1296 for “walking alone”), the 1-year information was selected as the preferred
data point.
Vision was assessed using the Cardiff Visual Acuity and Contrast Sensitivity
tests17 for binocular vision. These tests are indicators of the integrity of the visual
pathway and central nervous system and were considered robust “biological
controls”, complementing the fine and gross motor items. Importantly, both tests
are directly observed neurodevelopmental markers, unlikely to be affected by
cultural influences.
The administration of the INTERGROWTH-21st Neurodevelopment Package
was supported by an electronic and tablet-based data collection and management
system developed for this study, which contains the INTER-NDA operation
manual, visual cues, examples, and fully integrated quality checks13. Staff
administering the assessments were aware of the general principles of the Project
but not the specific hypothesis being tested. In addition, they were unaware of the
INTER-NDA domain and total scores for individual children, as well as for their
own and all the other study sites. Data were uploaded to centralised data-servers as
soon as each assessment ended. The data management team performed monthly
checks on the site-based and centralised databases (www.intergrowth21.org.uk/
protocol.aspx?lang=1).
Statistical analyses. The sample studied depended on pragmatic considerations.
The present report is the 2-year follow-up of the initial cohort of pregnant women
studied from early pregnancy1,8. The total number of eligible children to be
measured at 2 years of age was therefore fixed. The sample size estimations of the
original cohort (approximately 500 fetuses per site) focused on the precision and
accuracy of the extreme centiles of the complete population, i.e. the 3rd or 97th
centile because they correspond closely to ±2SD, and they are the recommended
cut-offs of the WHO Child Growth Standards, which are used internationally to
evaluate children of this age; however, in the present study, such estimations do not
apply because of the different nature of the hypothesis.
In this component of the study, the neurodevelopment of 1307 children was
evaluated at 2 years of age, an average of 261 children per site. This sample size was
considered adequate to explore the predicted small site-specific differences. Post-hoc
power calculations showed that the study was sufficiently powered to observe small
differences among study sites (calculations for all domains with power >0.99) and
small effect sizes for the between-group variances. For example, for a between-group
variance of 10% of the total variance and a two-tail alpha of 0.05, the power is 0.84.
Primary comparisons across sites were conducted using the average values of
cognition, attentional problems, fine motor, and gross motor, visual acuity and
contrast sensitivity scores. Expressive language, receptive language, positive,
negative and total behaviour, and social-emotional reactivity were considered
secondary outcomes. Members of the original INTERGROWTH-21st Neuro-
developmental Group selected these two groups of outcomes on an a priori basis,
founded on the literature and relative robustness of items used to assess the
primary outcomes to cultural influence.
Among the primary domains, the cognitive was also considered a priori to be
the most appropriate single primary outcome because its constituent items are
directly administered to the child in task-based sequences and are, therefore,
unaffected by recall or parental reporter bias. Furthermore, consistent associations
between prenatal/perinatal outcomes and cognitive scores at 2 years of age have
been reported54–57.
On the basis of our previous publications and WHO recommendations
for comparing the similarities in growth across populations2,4,5,8, we used
variance components analysis to calculate the percentage of total variance due to
between-country differences for each of the domains and the two visual tests.
Variance components were calculated by nonparametric generalised linear mixed
models (using the STATA package GLLAMM), which included as covariates sex,
fetal head circumference obtained between 26 and 34 weeks’ gestation (expressed as
z-scores of the international INTERGROWTH-21st Standards), age at assessment
in months and weeks and 2-year length and head circumference (expressed as
z-scores of the WHO Child Growth Standards). These variables were included as
fixed effects with study site as random effect. The method was chosen because it
assumes a discrete instead of a Gaussian distribution of the random effects and
showed better fit than Maximum Likelihood and Restricted Maximum Likelihood
models according to the lower Akaike information and Bayesian information
criteria.
In addition, for each of the domains and visual tests, SSD were calculated as the
difference between the mean from a given site and the mean of all sites together,
expressed as a proportion of the SD of the pooled data across sites for each specific
domain; means and SDs were adjusted by sex and age at examination (centred on
24 months of age). As pre-specified in the INTERGROWTH-21st Project protocol
and recommended by WHO8, SSD values in the range of ±0.5 units of the pooled
SD were taken as adequate to determine whether the data from all sites could be
pooled58.
For all analyses, Stata 15 software was used (StataCorp. 2017. Stata Statistical
Software: Release 15. StataCorp LLC, College Station, TX). Data were entered
locally into the specially developed, online data management system (http://
medscinet.com).
The INTERGROWTH-21st Project was approved by the Oxfordshire Research
Ethics Committee “C” (reference: 08/H0606/139), the research ethics committees
of the individual institutions and the regional health authorities where the project
was implemented. Written informed consent was obtained from all participants.
The sponsors had no role in the study design, data collection, analysis,
interpretation of the data, or writing of the paper. The following authors had access
to the full raw dataset: J.V., E.S.U., E.O. and S.K. The corresponding author had full
access to all the data and final responsibility for submitting the paper.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the corre-
sponding author upon reasonable request.
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